Notification of the emerging safety issues (ESI) to the State Agency of Medicines of Latvia

14.10.2014.

Notification of the emerging safety issues (ESI) to the State Agency of Medicines of Latvia

The marketing authorization holders should notify the emerging safety issues (ESI) regarding the medicinal products authorized in Latvia to the State Agency of Medicines of Latvia in writing:

via e-mail using the safe electronic signature (info@zva.gov.lv)
or
submit as an official paper form documents.Read more